Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
Tuesday, 20 April 2021, 15:29:29
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The COVID-19 pandemic shifted life as we knew it prompting the adoption of technological medical approaches. Telemedicine, for example, was widely criticized before and now is one of the most useful tools for better patient management and minimizing disruption in healthcare delivery. In today’s world, only companies that can adapt to new medical needs will be able to thrive. In fact, many companies such as Teladoc Health Inc (NYSE: TDOC ), Medtronic (NYSE: MDT ), Johnson & Johnson (NYSE: JNJ ) and Abbott Laboratories (NYSE: ABT ), among others, create offers specifically in the medtech industry. They understand that the future of healthcare will keep relying heavily on these innovations. Biotricity Inc. (OTCQB: BTCY ), a company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle, is also currently disrupting the market with its products.
Abbott Stock Is Trading Lower After Q1 Sales Shy Of Estimates
Tuesday, 20 April 2021, 15:09:01
Abbott Laboratories (NYSE: ABT ) has reported Q1 adjusted earnings of $1.32 per share on $10.5 billion in sales for its first quarter. Though EPS was above the estimated $1.27, revenues fell short of the expectation of $10.69 billion. In the year-earlier period, Abbott earned $0.65 per share and reported $7.73 billion in sales. For the year ending in 2021, the company still sees an adjusted profit of at least $5 a share … Full story available on Benzinga.com
Earnings Scheduled For April 20, 2021
Tuesday, 20 April 2021, 10:02:18
Companies Reporting Before The Bell • GATX (NYSE: GATX ) is projected to report quarterly earnings at $0.85 per share on revenue of $303.17 million. • Simmons First National (NASDAQ: SFNC ) is likely to report quarterly earnings at $0.51 per share on revenue of $197.48 million. • Aesthetic Medical Intl (NASDAQ: AIH ) is likely to report quarterly earnings at $0.10 per share on revenue of $54.06 million. • Badger Meter (NYSE: BMI ) is expected to report quarterly earnings at $0.42 per share on revenue of $120.40 million. • New Oriental Education (NYSE: EDU ) is estimated to report quarterly earnings at $0.07 per share on revenue of $1.14 billion. • Lockheed Martin (NYSE: LMT ) is estimated to report quarterly earnings at $6.30 per share on revenue of $16.33 billion. • Northern Trust (NASDAQ: NTRS ) is projected to report quarterly earnings at $1.48 per share on revenue of $1.54 billion. • Unique Fabricating (AMEX: UFAB ) is projected to report quarterly earnings at $0.07 per share on revenue of $35.
First-Quarter Earnings Season Is In Progress
Monday, 19 April 2021, 16:41:14
First-quarter earnings season continues this week after last week's reports were dominated by the big banks, with JPMorgan Chase & Co (NYSE: JPM ), The Goldman Sachs Group Inc (NYSE: GS ), and Morgan Stanley (NYSE: MS ) reporting record results as strong trading demand and rising interest rates fueled results. So far, corporate earnings have exceeded Wall Street's elevated expectations. This week, Netflix (NASDAQ: NFLX ) and Snap Inc (NYSE: SNAP ) will be among the major names reporting their first-quarter results. On Monday, Coca-Cola (NYSE: KO ) exceeded revenue and earnings estimates as fiscal first-quarter net income amounted to $2.25 billion. IBM (NYSE: IBM ), United Airlines (NASDAQ: UAL ) will report after the market closes. On Tuesday, Johnson & Johnson (NYSE: JNJ ), Harley-Davidson Inc (NYSE: HOG ), Abbott Laboratories (NYSE: ABT ), Procter & Gamble (NYSE: PG ), Lockheed Martin (NYSE: LMT ), Philip Morris International (NYSE: PM ) will report before the market opens. Netflix (NASDAQ: NFLX ) will report after the market closes.
Abbott's Upgraded TriClip Heart Valve System OK'd In Europe
Thursday, 8 April 2021, 19:38:03
Abbott Laboratories (NYSE: ABT ) won European approval for the latest generation of its TriClip system, a transcatheter-based repair device designed to stem leaks in the heart’s tricuspid valve. The tricuspid valve opens and closes a set of three flaps rather than two. Because of that complexity, patients with tricuspid valve problems … Full story available on Benzinga.com
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.